Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001662114-17-000001
Filing Date
2017-01-04
Accepted
2017-01-04 12:09:14
Documents
1
Effectiveness Date
2017-01-04
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 14415
  Complete submission text file 0001662114-17-000001.txt   15438
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 (206) 957-7300
Lodo Therapeutics Corp (Filer) CIK: 0001662114 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-254438 | Film No.: 17504198